Key Details
Price
$2.14Annual Revenue
$112.25 MAnnual EPS
-$0.08Annual ROE
-4.70%Beta
1.71Events Calendar
Next earnings date:
Mar 07, 2025Recent quarterly earnings:
Nov 07, 2024Recent annual earnings:
Mar 07, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Nov 04, 2013Analyst ratings
Recent major analysts updates
Market Data
Dividend
Profitability
Efficiency
Valuation
Liquidity
Cash Flow
Institutional Ownership
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q3 2024 Results Conference Call November 7, 2024 8:00 AM ET Company Participants Kathryn Flynn - Corporate Controller James Green - Chairman, President and CEO Jennifer Cote - CFO Conference Call Participants Paul Knight - KeyBanc Bruce Jackson - The Benchmark Company Operator Good day, and welcome to the Third Quarter 2024 Harvard Biosciences Inc. Earnings Conference Call. [Operator Instructions] As a reminder, this call may be recorded.
HOLLISTON, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2024 before the market opens on November 7, 2024, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
Solutions for CROs, pharma and biotechs streamline testing and enable fundamental advancements in preclinical and organoid focused therapy development Solutions for CROs, pharma and biotechs streamline testing and enable fundamental advancements in preclinical and organoid focused therapy development
HOLLISTON, Mass., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Sidoti Small Cap Virtual Conference on September 18th, 2024, with a presentation time of 9:15 am ET.
Harvard Bioscience, Inc. (NASDAQ:HBIO ) Q2 2024 Earnings Conference Call August 8, 2024 10:00 AM ET Company Participants Kathryn Flynn - Corporate Controller James Green - Chairman, President and CEO Jennifer Cote - CFO Conference Call Participants Paul Knight - KeyBanc Capital Markets Bruce Jackson - The Benchmark Company Christopher Sakai - Singular Research Operator Good day, and thank you for standing by. Welcome to the Q2 2024 Harvard Bioscience, Inc. Earnings Conference Call.
HOLLISTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2024 before the market opens on August 8, 2024, and will hold a conference call to discuss the results at 10:00 a.m. Eastern Time.
HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14th Annual East Coast IDEAS Conference at the Jay Conference Center – Bryant Park in New York City on June 12, 2024.
Harvard Bioscience, Inc. (Nasdaq: HBIO) disclosed that Jim Green, Chairman and CEO, and Jennifer Cote, CFO, will take part in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, including a live fireside chat at 9:00-9:40 am ET. The Company will also hold individual meetings with investors during the Conference.
Harvard Bioscience, Inc. (Nasdaq: HBIO) is scheduled to release its financial results for the quarter ending on March 31, 2024 before the market opens on May 7, 2024. A conference call to discuss the results will take place at 8:00 a.m. Eastern Time.
HOLLISTON, Mass., March 11, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, will be presenting to investors at the upcoming Sidoti Small Cap Conference and KeyBanc Life Sciences & MedTech Conference, both to be held virtually in March 2024. Joining him will be Jennifer Cote, the Company's Chief Financial Officer.
FAQ
- What is the primary business of Harvard Bioscience?
- What is the ticker symbol for Harvard Bioscience?
- Does Harvard Bioscience pay dividends?
- What sector is Harvard Bioscience in?
- What industry is Harvard Bioscience in?
- What country is Harvard Bioscience based in?
- When did Harvard Bioscience go public?
- Is Harvard Bioscience in the S&P 500?
- Is Harvard Bioscience in the NASDAQ 100?
- Is Harvard Bioscience in the Dow Jones?
- When was Harvard Bioscience's last earnings report?
- When does Harvard Bioscience report earnings?
- Should I buy Harvard Bioscience stock now?